SOT Award Recipients · Garrobo,” is a flamenco guitarist based in San Antonio. He studied the...

43

#20

18SO

T

#to

xexp

oAW

ARD

S

SOT Award Recipients

Achievement Award

Dana C. Dolinoy

Dana C. Dolinoy, PhD University of Michigan School of Public Health, Ann Arbor, MI

A graduate of Duke University, Dr. Dolinoy received her PhD in genetics and genomics and integrated toxicology and environmental health in 2007. She received her postdoctoral training in radiation oncology at Duke. Currently, she serves as the NSF International chair of environmental health sciences and associate professor of nutritional sciences

and of environmental health sciences at the University of Michigan School of Public Health. She also bears the distinction of serving as faculty director for the Epigenomics Core at the University of Michigan Medical School.

Her broad background in genomics and toxicology with specific training and expertise in epigenetic research is evidenced by her impressive list of publications. She has published 80 peer-reviewed manuscripts in high-quality scholarly journals and 10 peer-reviewed book chapters. In addition, she has participated in more than 100 extracurricular invited presentations, advisory panels, and chairmanships. Within a short timeframe, Dr. Dolinoy has established herself as a researcher on the cutting edge of the toxicological sciences.

Dr. Dolinoy has been continually supported by competitive external grant funding since 2009. Her work on the understanding of the fetal basis of adult disease, “In Utero Exposure to Bisphenol A: Effects on the Fetal Epigenome,” earned her a National Institute of Environmental Health Sciences (NIEHS) Outstanding New Environmental Scientist (ONES) Award. This work combined animal models and human clinical approaches to identify epigenetic mechanisms underlying toxicant-induced disease outcomes and will continue to have broad-reaching impacts on research, teaching, and the protection of public health.

As a principal investigator within the NIEHS/US Environmental Protection Agency-funded Michigan Children’s Environmental Health and Disease Prevention P01 Center, her current work focuses on developmental exposures to complex mixtures and risk for later-in-life disease, including metabolic syndrome. Dr. Dolinoy also serves as principal investigator of a U01 Award within the NIEHS Toxicant Exposures and Responses by Genomic and Epigenomic Regulators of Transcription (TaRGET) II consortium. In 2015, Dr. Dolinoy received the National Institutes of Health Director’s Transformative Research R01 Award to develop novel epigenetic editing tools to reduce disease risk. Her transformative work has been described as

SOT Awards

Awards Ceremony MusicSunday Afternoon, March 11, 4:45 PM to 5:15 PM CC Stars at Night Ballroom B1

Performed by Randy Cordero

Randy Cordero, also known as “El Garrobo,” is a flamenco guitarist based in San Antonio. He studied the art of flamenco both in Spain and in the US. His musical style is a blend of traditional Jerez-style

flamenco with some contemporary influences.

Awards CeremonySunday Afternoon, March 11, 5:15 PM to 6:30 PM CC Stars at Night Ballroom B1

Please join the Awards Committee, in conjunction with Council, the Board of Publications, and the Education Committee, as they honor distinguished scientists at the prestigious SOT Awards Ceremony. Also conferred at this ceremony are a number of grants, fellowships, and awards for cutting-edge and novel research. Please refer to the Awards and Funding section of the SOT website for complete details at www�toxicology�org/awards.

Endowment Fund 2017 AwardsThe Endowment Fund Awards are conferred during the Annual Meeting. View the names of the recipients of the SOT Endowment 2017 Awards during the musical performance. SOT Endowment Funds have a mission of assisting in advancing toxicology by providing financial support for the Society’s programs. The vision for the SOT Endowment Fund is to establish and increase in net worth a set of Endowment Funds that will provide significant, stable, long-term financial support to aid in achieving the Society’s strategic objectives. To learn more visit www�toxicology�org/endowment.

http://www.toxicology.org/awards

http://www.toxicology.org/endowment

44

Mobile Event A

ppAW

ARD

S

innovative, unconventional, and paradigm shifting. She is creative thinker and an example of a scientist that will continue to push boundaries.

An SOT member since 2005, Dr. Dolinoy became a Toxicological Sciences associate editor in 2014 and joined the SOT Board of Publications in 2015. She currently serves as vice president-elect of the Molecular and Systems Biology Specialty Section. She has received numerous awards, including the Women in Toxicology Specialty Interest Group 2017 Young Investigator Award.

Arnold J� Lehman Award

Linda S. Birnbaum

Linda S. Birnbaum, PhD, DABT, ATS NIEHS, Research Triangle Park, NC

Dr. Birnbaum received her PhD in microbiology from the University of Illinois at Urbana-Champaign. After several years in academia, she joined the National Institutes of Health (NIH) as a senior staff fellow in the National Toxicology Program (NTP). While at NIH, she received tenure and led the National Institute of Environmental Health Sciences (NIEHS) Chemical Disposition Group.

Dr. Birnbaum then moved to the US Environmental Protection Agency (US EPA), where she worked for 19 years, mostly as the director of the Experimental Toxicology Division. Then, in 2009, she returned to NIEHS and NTP as director. From her years at the US EPA to her current position at NIEHS, Dr. Birnbaum’s contributions to risk assessment and the regulation of environmental chemicals have exemplified the type of impact this award is designed to recognize.

Dr. Birnbaum’s expertise with persistent organic pollutants, such as dioxins and polychlorinated biphenyls (PCBs), led to her revolutionizing the principles of toxicology risk assessment through approaches such as the body-burden assessments and developmental susceptibility models. With international collaboration, Dr. Birnbaum was instrumental in the development of toxic equivalency factors (TEFs), transforming the ability to assess risk from different environmental mixtures. Further, she is one of the first scientists to perform regulatory science research on brominated flame retardants and to apply this research to enhance the risk assessment of this class of agent. Her work to understand the pharmacokinetics and developmental impact of these agents has led to modifications or total bans of these chemicals to reduce or eliminate the health risk.

Dr. Birnbaum has authored more than 600 publications, many of which attest to her impact on regulatory toxicology and risk assessment. She is a member of the US National Academy of Medicine and has held leadership roles for the International Union of Toxicology (IUTOX), the Academy of Toxicological Sciences, and the American Aging Association.

A highly active member of the Society since 1982, Dr. Birnbaum served as the organization’s president for 2004–2005, as well as serving on many SOT Committees over the years, including the Awards, Nominating, Scientific Program, and Finance Committees.

Best Postdoctoral Publication Awards

The Postdoctoral Assembly congratulates these three recipients for their accomplishments. These awards are presented during the Postdoctoral Assembly Luncheon on March 13, 2018.

Colette N. Miller

Colette N. Miller, PhD, US EPA, Research Triangle Park, NC

Miller, CN, JA Dye, AD Ledbetter, MC Schladweiler, JH Richards, SJ Snow, CE Wood, A Henriquez, LC Thompson, A Farraj, M Hazari, and UP Kodavanti. 2017. “Uterine Artery Flow and Offspring Growth in Long-Evans Rats Following Maternal Exposure to Ozone During Implantation.” Environmental Health Perspectives 125(12):127005.

Sreenivasa C. Ramaiahgari

Sreenivasa C. Ramaiahgari, PhD, NIEHS, Research Triangle Park, NC

Ramaiahgari, SC, S Waidyanatha, D Dixon, M DeVito, R Paules, and S Ferguson. 2017. “Three-Dimensional (3D) HepaRG Spheroid Model with Physiologically-Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.” Toxicological Sciences 159, no. 1 (September): 124–136. https://doi. org/10.1093/toxsci/kfx122.

Priyanka Trivedi

Priyanka Trivedi, PhD, Harvard Medical School, Boston, MA

Trivedi P, RK Kumar, A Iyer, S Boswell, C Gerarduzzi, VP Dadhania, Z Herbert, N Joshi, JP Luyendyk, BD Humphreys, and VS Vaidya. 2017. “Targeting Phospholipase D4 Attenuates Kidney Fibrosis.” Journal of the American Society of Nephrology DOI: 10.1681/ASN.2016111222.

http://www.toxicology.org/mobileapp

https://doi

45

#20

18SO

T

#to

xexp

oAW

ARD

S

Distinguished Toxicology Scholar Award

Roger O. McClellan

Roger O. McClellan, DVM, MMS, DSc (Honorary), DABT, DABVT, ATS, Member-NAM Toxicology and Human Health Risk Analysis, Albuquerque, NM

Dr. McClellan is receiving the 2018 SOT Distinguished Toxicology Scholar Award for his substantial and seminal scientific contributions to the understanding of radiation toxicology and the broader impact of this body of research on the field of toxicology.

During high school in Richland, Washington, site of the Hanford Atomic Products Operation, Dr. McClellan was introduced to the science of radiation and its effects on health. As a Washington State University (WSU) student, he worked with Hanford scientists as an intern on radiation issues. His research on metabolism and dosimetry of Zn65 in sheep was used as an honor’s thesis for his Doctor of Veterinary Medicine with Highest Honors from WSU in 1960.

Dr. McClellan then joined the Hanford Laboratories’ staff, conducting research on transfer of radionuclides through ecosystems, intake by livestock and humans, and exposure-dose-response relationships for endpoints from reproductive effects to cancer. He had responsibility for a major lifespan study on health effects of Sr90 ingestion by miniature pigs. Another major study was on transfer of I131 from cows to cow’s milk to human thyroid. This work became predictive of effects to human populations after the Chernobyl reactor accident. In 1965, Dr. McClellan was assigned to the US Atomic Energy Commission (AEC) with responsibility for the AEC Internally-Deposited Radionuclides Program. The next year, he assumed leadership of what became the Lovelace Inhalation Toxicology Research Institute (LITRI), Albuquerque, New Mexico, whose mission was to provide information for evaluating health consequences of catastrophic reactor accidents. He quickly recruited a multidisciplinary team to investigate health effects of inhaled radionuclides in various forms. This series of studies continued for more than three decades—unparalleled in experimental toxicology. The peer-reviewed publications from this research comprise a substantial portion of the world’s literature in this field, providing a basis for establishing radiation protection standards and evaluating the consequences of nuclear accidents. Dr. McClellan was president and scientific leader (1988–1999) of the Chemical Industry Institute of Toxicology (CIIT) before becoming an independent advisor on inhalation toxicology and risk analysis.

For more than 60 years, Dr. McClellan has been a leading scholar, improving knowledge of the health effects of exposure to radionuclides and air contaminants. His contributions have come from his work as an investigator and team leader. He has strongly advocated “issue-resolving” research that reduces scientific uncertainty in assessing safety and risks of various technologies. He has authored 350 papers, edited 10 books, and contributed to numerous reports by advisory committees of the National Council on Radiation Protection, the National Research Council, eight federal agencies, and the National Academy of Medicine to which he was elected in 1990.

For his many enduring contributions to development of knowledge on toxicology of airborne toxicants, Dr. McClellan has received the SOT Arnold J. Lehman Award (1992), Merit Award (2005), and Founder’s Award (2009), as well as numerous honors from other organizations. Dr. McClellan has been an active SOT member, serving on many SOT Committees, on the SOT Council, as founding chair of the SOT Endowment Fund Board, and as SOT president 1989–1990.

Distinguished Toxicology Scholar Award Lecture: Sixty Years of Contributions to Understanding Radionuclide Toxicity, Monday, March 12, 12:30 pm to 1:30 pm, CC Hemisfair Ballroom C2�

Education Award

Judith T. Zelikoff

Judith T. Zelikoff, PhD New York University School of Medicine, Tuxedo Park, NY

Dr. Zelikoff has made significant contributions to toxicology education. She has an uncanny ability to communicate high-level toxicology research in a way that makes it understandable to students at every level of training and also to members of the general public. Through her lectures, she brings outthe importance of the science and the

excitement of discovery in the findings within the field.

Dr. Zelikoff joined the faculty at the New York University (NYU) School of Medicine in 1982, where she presently serves as a tenured full professor for the Department of Environmental Medicine. Her research is focused in the areas of developmental immunotoxicology and reproductive and pulmonary toxicology associated with tobacco products and ambient air pollution.

A sought-after educator, Dr. Zelikoff effectively incorporates her research programs with other teaching commitments to educate undergraduates as well as graduate students. She has provided research experience to 12 high school students and to six undergraduate students. Dr. Zelikoff has successfully mentored 27 masters students and 10 PhD students, and she has served on a number of thesis committees. Through her guidance and mentorship, her students have been known to be extremely well-prepared, even when presenting their talks for the first time. In addition to teaching toxicology nationally, she has mentored a number of international students, and her teaching experience spans the globe to include countries such as Australia, Nigeria, New Zealand, Jamaica, India, Nepal, and Thailand.

As the Community Outreach and Education Program director of the NYU National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences Core Center, Dr. Zelikoff also is very active in education about toxicology to non-toxicologists and underserved minorities. In this capacity, she works to educate and guide environmentally-impacted communities about toxic pollution, contaminant-associated health outcomes, and possible intervention strategies.

Dr. Zelikoff treats her students with respect, while at the same time expecting a lot from each. She shows genuine interest in their development as students, as well as their professional development as scientists. Her teaching style is very

46

Mobile Event A

ppAW

ARD

S

straightforward and enthusiastic. This technique gains the trust of her students and people learn better as a result. Dr. Zelikoff often reiterates that the best part of her job is the students and knowing she played a role in their professional growth and success.

A member of the Society since 1986, Dr. Zelkoff has been very active within education initiatives, serving as chair of Education Committee and as chair of the Committee for Diversity Initiatives. In addition, she has served as SOT Secretary and within the leadership of various SOT Specialty Sections and Regional Chapters, including currently as president of the Ethical, Forensic, Legal, and Societal Issues Specialty Section. Also, as a testament to her dedication and commitment to toxicology education, she was honored in 2015 by the Women in Toxicology Special Interest Group with its Mentorship Award. In 2012, she was selected as a host for the SOT Global Senior Scholar Exchange Program and received the 2012 Career Achievement Award in Immunotoxicology from the Immunotoxicology Specialty Section.

Enhancement of Animal Welfare Award

Anna B. Lowit

Anna B. Lowit, PhD US EPA, Washington, DC

Dr. Lowit received a Master of Science in environmental toxicology and a PhD in environmental toxicology from the University of Tennessee. Currently, she serves as a senior science advisor for the US Environmental Protection Agency (US EPA) in the Office of Pesticide Programs. She was elected co-chair of and represents the US EPA on the Interagency Coordinating Committee on the Validation

of Alternative Methods (ICCVAM), a permanent committee under the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). The ICCVAM is a committee of representatives from 16 federal agencies that require, use, generate, or disseminate toxicological and safety testing information.

In her role at the US EPA, Dr. Lowit has led various important initiatives advancing the agency’s strategic vision to adopt 21st-century, human-relevant in vitro and in silico testing approaches. These approaches have led directly to the development and implementation of strategies and programs to improve risk assessments while reducing animal use in toxicity testing. Because of her commitment to the 3Rs (replacement, reduction, and refinement of animal use in scientific research), the Office of Pesticide Programs developed and implemented a transparent, stepwise process for evaluating and implementing alternative methods of testing for acute oral, dermal, and inhalation toxicity, as well as eye irritation and skin and eye sensitization.

An internationally-recognized and well-respected expert in alternatives to animal testing, Dr. Lowit has served on numerous committees related to advancing the 3Rs, including the ILSI Health and Environmental Sciences Institute (HESI) committees on 21st-century risk assessment and non-animal test methods.

She is committed to collaboration and encourages others to develop partnerships to effectuate change in furthering the science and implementing real change in policy.

Dr. Lowit has been an active member of the Society since 2005. She has served as a councilor for the Risk Assessment Specialty Section and regularly presents at the SOT Annual Meeting and ToxExpo on topics such as the application of the 3R principles of animal welfare to the testing of agrochemicals and the alternative approaches for skin sensitization testing.

Founders Award

Ruth A. Roberts

Ruth A. Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath ApconiX, Alderley Edge, United Kingdom

Dr. Roberts is chair and director of drug discovery at the University of Birmingham, United Kingdom, and director and co-founder of ApconiX, a provider of nonclinical safety expertise. Previously, she worked in senior roles in regulatory safety globally, drug discovery and development, and scientific strategy for companies such as AstraZeneca, ICI,

Syngenta, and Aventis. In a career spanning 30 years, Dr. Roberts is an expert multidisciplinary and influential scientist working at the intersection where industry meets academia.

A graduate of the University of Manchester, she received her PhD in 1987. She was bestowed the SOT Achievement Award in 2002 for her contributions to the molecular understanding of toxicity and received the EUROTOX Bo Holmstedt Award in 2008 in recognition of scientific excellence in the area of drug and chemical safety.

Dr. Roberts has authored more than 140 peer-reviewed publications. Her reputation as a world-class investigator in drug and chemical safety is evidenced by more than 30 invitations to speak about her research from all over the world within the last 10 years. She is a highly-sought-after expert in drug discovery and development problem solving and scientific strategy.

More recently, Dr. Roberts’ focus has been on translational research in the understanding of the influence of ion channel research on development of new therapeutics. Her current strategies rely on the synthesis of basic research and clinical application to gain further, more in-depth understanding with a goal of improving human health.

Dr. Roberts’ dedication to leadership within the field of toxicology is clearly demonstrated, such as her service as chair for the ILSI Health and Environmental Sciences Institute (HESI) Emerging Issues Committee, which helps to determine the next level for research topics for a global organization to improve approaches to risk assessment and safety. Furthermore, she has been elected to the presidential chain of societies such as The British Toxicology Society, EUROTOX, and the Academy of Toxicological Sciences and currently is serving as SOT secretary.


47

#20

18SO

T

#to

xexp

oAW

ARD

S

Global Senior Scholar Exchange Program

Aina O. Adeogun

Aina O. Adeogun, PhD, University of Ibadan, Ibadan, Nigeria

Dr. Adeogun is an associate professor/reader in the Department of Zoology, University of Ibadan, Ibadan, Nigeria. Dr. Adeogun’s research focus involves the evaluation of environmental impact and risk assessment as a tool for the development and validation of sensitive biomarkers for endocrine, neuro, and reproductive toxicology, particularly in aquatic organisms. Specifically, Dr. Adeogun is hopeful to conduct research on plastic products as vectors of contaminants in drinking

water in Nigeria and anticipates that the GSSEP award will provide opportunities to strengthen collaborations with Dr. Arukwe to support the development and training of young toxicologists and scientists from Nigeria. The improvement of toxicology curriculum content for toxicology courses will be a focus to help improve toxicological studies at the University of Ibadan and other schools in the region. Dr. Adeogun is a founding member of the Forum of Ibadan Toxicologists, formed in 2014 to encourage collaborative research amongst toxicologists in Southwest Nigeria.

Augustine Arukwe

Host: Augustine Arukwe, DSc, Norwegian University of Science and Technology, Trondheim, Norway

Dr. Arukwe is a European Registered Toxicologist and professor in the Department of Biology at the Norwegian University of Science and Technology, Trondheim, Norway. His research focuses on mecha-nistic toxicology, the functional and regulatory aspects of differentially expressed genes, proteins, and enzymes, and the general stress of contaminants

including endocrine modulators in wildlife species and fish reproductive toxicology. Dr. Arukwe has extensive international collaborations, including a self-initiated environmental biomon-itoring program in Nigeria, a consultancy for the United Nations University–International Network on Water, Environment, and Health, and he served previously as a GSSEP ToxScholar host. Dr. Arukwe is committed to working with Dr. Adeogun to continue building capacity for sustainable environmental human health management in Nigeria.

Hilmi Orhan

Hilmi Orhan, PhD, ERT, Ege University, Izmir, Turkey

Dr. Orhan is professor of toxicology in the Department of Pharmaceutical Toxicology at Ege University in Turkey. He served as the secretary general of the Turkish Society of Toxicology 2005–2011 until elected as president of the society in 2011 and was re-elected for the same position in 2013. He has served as the secretary general for the Molecular Toxicology Specialty Section of the Association of

European Toxicologists and European Societies of Toxicology (EUROTOX) since 2009, and he was elected as the chair of

this section in 2014. He has been a member of the Executive Committee of EUROTOX since 2013. Dr. Orhan was the recipient of a Bo Holmstedt Fellowship Award in 2008.

His current research involves the characterization of reactive intermediates upon biotransformation of drugs and drug candidates by target organs and subcellular compartments such as mitochondria and investigation of their contribution to adverse effects. He is also interested in the application of biomarkers in both clinical and environmental toxicological studies in human tissues. This includes exploration of the possible associations between persistent organic pollutants concentrations and cancers in patients.

Hartmut Jaeschke

Host: Hartmut Jaeschke, PhD, ATS, FAASLD, University of Kansas Medical Center, Overland Park, KS

Dr. Jaeschke is professor and chair of the University of Kansas Medical Center’s Department of Pharmacology, Toxicology, and Therapeutics. He serves on numerous science- and toxicology-related boards and is elected to the Academy of Toxicological Sciences and a fellow of the American Association for the Study

of Liver Diseases. He is a recent recipient of the John Doull Award, presented by the Central States Regional Chapter of the Society of Toxicology. As a host to Dr. Orhan, Dr. Jaeschke and his colleagues will provide information related to the graduate school curriculum in toxicology as well as their program in translational toxicology, specifically related to mechanistic biomarkers of mitochondrial damage, which are of interest to Dr. Orhan. Dr. Jaeschke is hopeful that this collaboration will enhance the Ege University graduate education program and also lead to the establishment of an exchange program with the University of Kansas Medical Center.

Merit Award

Robert J. Kavlock

Robert J. Kavlock, PhD Washington, DC

Dr. Kavlock has been selected as the recipient for the Merit Award in recognition of his distinguished contributions to toxicology throughout his career as a scientist and later as a leader in the field of computational toxicology. For more than 40 years, Dr. Kavlock conducted research and led the science at the US Environmental Protection Agency (US EPA). He began at the US EPA as a

biological researcher and worked his way up through the agency, becoming branch chief and then director of the Reproductive Toxicology Division. In 2004, he began laying down the foundation with like-minded, computationally-inclined colleagues which resulted in the creation of US EPA’s National Center for Computational Toxicology (NCCT) in 2005. Under his leadership as founding director, NCCT became a major innovative force for change within the US EPA, operating under a mandate to bring modern computational tools, technologies,

48

Mobile Event A

ppAW

ARD

S

and expertise to help transform toxicological research within the agency. He was a visionary and was instrumental in the launching of the US EPA Toxicity Forecaster (ToxCast).

In 2007, the National Academy of Sciences reinforced the directions of the US EPA’s computational toxicology program in its report Toxicity Testing in the 21st Century: A Vision and a Strategy. Dr. Kavlock helped forge the creation of Toxicology in the 21st Century (Tox21), which brought together the US EPA, National Institutes of Health (NIH), and later the US Food and Drug Administration (US FDA) in a coordinated and complementary research consortium. Subsequently, the US EPA’s computational toxicology program created publicly-available databases, which provide easy access to toxicological information on more than 500,000 chemicals, representing findings from 30+ years of animal toxicity studies; high-throughput screening data on nearly 3,000 chemicals; and information on the use of more than 40,000 chemicals in consumer products.

Dr. Kavlock accepted the position of deputy assistant administrator for the US EPA Office of Research and Development in 2012 and became acting assistant administrator in 2017. In these roles, Dr. Kavlock was routinely faced with complex scientific issues which required his ready knowledge and understanding of the subtle nuances in order make decisions that impacted his department, his agency, the United States, and beyond. More recently, Dr. Kavlock led a workshop of international regulators to understand barriers to alternative methods in risk assessment and how to increase acceptance globally.

A highly-productive scientist, Dr. Kavlock has more than 200 peer-reviewed publications. His work has been cited more than 11,000 times, a testament to the extent his peers value his contributions. He has received numerous awards, including many high-level awards within and outside of the US EPA.

An SOT member since 1988, Dr. Kavlock has been very active and has participated on many Society committees. He served as president of the North Carolina Regional Chapter, president of the Reproductive and Developmental Toxicology Specialty Section, and on the Editorial Board for Toxicological Sciences.

Perry J� Gehring Diversity Student Travel Award

This award is presented during the CDI Reunion.

Kimberly A. Rivera-Caraballo

Kimberly A. Rivera-Caraballo, University of Puerto Rico at Humacao, Humacao, PR

Abstract Number: 1483 Poster Board Number: P636

Abstract Title: Expression of Excitatory Amino Acid Transporter miRNA During Methylmercury Exposure in Mouse Spinal Cord Astrocytes and Neuroblastoma Spinal Cord NSC-34 Cells

Institution Where Research Was Conducted: Michigan State University

Pfizer SOT Undergraduate Student Travel Awards

Alyssa Bellomo

Alyssa Bellomo, Kean University, Union, NJ


Abstract Title: Receptor for Advanced Glycation End-Products (RAGE) Expression in Nitrogen Mustard-Induced Acute Lung Injury in Rats

Institution Where Research Was Conducted: Rutgers, The State University of New Jersey

Colin Graham Cess

Colin Graham Cess, University at Buffalo, Buffalo, NY


Abstract Title: Characterization of Biomarkers of Platelet Activation and Stress for Preclinical Toxicology Studies

Institution Where Research Was Conducted: Boehringer Ingelheim

Irisyunuel Lopez Hernandes

Irisyunuel Lopez Hernandes, North Carolina Central University, Durham, NC


Abstract Title: Development and Validation of Cell-Based Assay to Screen for Compounds That Modulate Glutamate-Induced Cell Death

Rabia Javed

Rabia Javed, John Jay College of Criminal Justice, New York, NY


Abstract Title: Thymoquinone Attenuates Maneb and Mancozeb-Induced Cytotoxicity


49

#20

18SO

T

#to

xexp

oAW

ARD

S

Yoomin Jo

Yoomin Jo, Baylor University, Waco, TX


Abstract Title: Role of Directly and Indirectly Acting Chemicals on Development and Oxidative Stress in Various Early Life Stages

Emily Measel

Emily Measel, University of Georgia, Athens, GA

Platform Abstract Number: 3275

Abstract Title: Bisphenol AF Induces Multinucleation in Mouse Spermatogonial Cells In Vitro

Ricardo A. Navarro Dent

Ricardo A. Navarro Dent, University of Puerto Rico at Mayaguez, Mayaguez, PR


Abstract Title: Induction of DNA Damage and Stress Responses by the Sulfur Mustard Analog Mechlorethamine in Human HaCaT Keratinocytes


Jacob A. Noeker

Jacob A. Noeker, College of Idaho, Caldwell, ID


Abstract Title: The Effect of Electronic Cigarette Liquids (E-Liquids) on the Human Osteoblast-Like Cell Line Saos-2

Claire E. Otero

Claire E. Otero, College of Idaho, Caldwell, ID


Abstract Title: Electronic Liquids Induce Osteotoxicity in Which Flavoring Is a Key Factor

Brittany P. Rickard

Brittany P. Rickard, University of the Sciences, Philadelphia, PA


Abstract Title: Tissue Distribution of Organophosphate Flame Retardants in Mice: Analysis of Dose-Dependency, Chemical Species, and Sex Differences in a Subchronic Study


Adrianna B. Suazo

Adrianna B. Suazo, Northern New Mexico College, Española, NM


Abstract Title: Acute Methylmercury Exposure Alters Immunofluorescence of the Renshaw Cell Area in C57BL/6J Mice

Institution Where Research Was Conducted: Michigan State University

Jennifer J. Tao

Jennifer J. Tao, Rutgers, The State University of New Jersey, Piscataway, NJ


Abstract Title: Effects of Oxidants on Human Superoxide Dismutase (SOD)

Steven J. Toro De León

Steven J. Toro De León, University of Puerto Rico at Humacao, Humacao, PR


Abstract Title: Increased Levels of Methionine Sulfoxide Associated with an APAP Autoprotection Mouse Model Do Not Confer Cytoprotection against APAP In Vitro in HC04 and HepaRG Cells

Institution Where Research Was Conducted: University of Connecticut

Makeba A. Walcott

Makeba A. Walcott, Vassar College, Poughkeepsie, NY


Abstract Title: MyomiR Regulation of Pulmonary Response to Smoking and Diet-Induced Obesity

Institution Where Research Was Conducted: Oregon State University

50

Mobile Event A

ppAW

ARD

S

Public Communications Award

Maureen R. Gwinn

Maureen R. Gwinn, PhD, DABT, ATS US EPA, Washington, DC

Dr. Gwinn serves as a senior science advisor in the US Environmental Protection Agency (US EPA) Office of Research and Development (ORD). In her more than 10 years at the US EPA, she also has worked on human health hazard assessments for the agency’s Integrated Risk Information System (IRIS) Program and served as the associate national program director for community public health research in

the US EPA Sustainable and Healthy Communities Research Program.

Dr. Gwinn is a very productive and well-respected scientist internationally, who is renowned in nanotoxicology, asbestos research, and chemical risk assessment. She was on the Editorial Board for the Journal of Nanomedicine and Nanotechnology and serves as an ad hoc reviewer for other journals, such as Cancer Research, Toxicological Sciences, and the Journal of Toxicology and Environmental Health.

Demonstrating her dedication to the accurate communication of toxicology to raise public awareness, especially to the next generation of toxicologists, Dr. Gwinn actively participates in public outreach efforts. Within the US EPA, she has spearheaded several initiatives to broaden the reach of toxicology. She was the lead for the ORD’s hands-on activity for EPA@40, an US EPA-sponsored, two-day celebration of Earth Day and the US EPA’s 40th Birthday, training volunteers and conducting an “Assuring the Safety of Chemicals” activity where more than 1,000 children and adults participated. Since 2009, Dr. Gwinn also has participated in the US EPA Summer Educational Development Program, as well as represented the agency at the USA Science and Engineering Festival. She also has participated in the “Every Girl Can—Smart Image” conference at Bowie State University to inspire young women to consider science careers.

An SOT member since 2005, Dr. Gwinn has been very active in numerous elected and nominated capacities related to toxicology education and public awareness of toxicology. She served as president of the Allegheny-Erie Regional Chapter and was the task force lead for K–12 outreach activities in conjunction with the SOT Annual Meeting and ToxExpo in 2009 and 2011. She has served on the SOT Education K–12 Subcommittee, as well as the Education Committee, and worked with the National Capital Area Regional Chapter to support an annual event to bring toxicology-rich science to Girl Scouts in the region for more than seven years. She also worked with the Northern California Regional Chapter to co-host an “Open Science Day” at the University of California-Berkeley Lawrence Hall of Science during the free public event “What Do Snow White, Romeo and Juliet, and The Mad Hatter Have in Common? … Toxicology!” Through the SOT ToxScholar Program, Dr. Gwinn has visited multiple undergraduate institutions underrepresented in toxicology to encourage students to consider toxicology education or careers. She also has authored or co-authored multiple toxicology education outreach posters presented during SOT Annual Meetings.

SOT/SOT Endowment Fund/IUTOX Travel Awards

Dania Bacardí Fernandez

Dania Bacardí Fernandez, MSc, PhD, Center for Genetic Engineering and Biotechnology, Havana, Cuba

Orleans N.K. Martey

Orleans N.K. Martey, MSc, University of Otago, North Dunedin, New Zealand

Olusola Oladipo

Olusola Oladipo, DVM, MSc, PhD, University of Jos, Jos, Plateau, Nigeria

Vijay V. Pillay

Vijay V. Pillay, MD, DCL, Amrita Institute of Medical Sciences & Research, Cochin, Kerala, India


51

#20

18SO

T

#to

xexp

oAW

ARD

S

Wells Utembe

Wells Utembe, PhD, National Institute for Occupational Health, Johannesburg, Gauteng, South Africa

SOT Undergraduate Intern Travel Award

Natalie N. Alvarez

Natalie N. Alvarez, Clemson University, Clemson, SC


Abstract Title: DHA Supplemented Diet Reduces Nanoparticles-Induced Lung Inflammation with Methylation Changes

Institution Where Research Was Conducted: University of Montana

Toxicological Sciences Paper of the Year Award

Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Leah M. Norona, Deborah G. Nguyen, David A. Gerber, Sharon C. Presnell, and Edward L. LeCluyse. Toxicological Sciences, 154, no. 2 (December 2016): 354–367. https://doi.org/10.1093/toxsci/kfw169.

The use of 3D printers has revolutionized many aspects of manufacturing. Plastics,

resins, and metallic-based materials are able to build objects with printing technology. These systems allow one to use computer-aided design (CAD) packages to make small specialty parts that historically would have required a very labor and skill-intensive machinist. The approach took off in industry sectors were specialty parts needed to be made to exacting specifications. The medical sector also was able to take advantage of this for the construction of small medical devices and parts. In the paper by Norona et al., they show what happens when the above technology is combined with biology.

Toxicologists have been studying cells in monolayers for decades. Various co-cultures and cell clusters or spheres also have been developed which provide more of the natural architecture. However, some cell systems are not amendable to this sort of spatial reconstruction. In collaboration with Organova, the authors used 3D printing technology to create their biological model. In this case, the inks were not pigments or plastics, but parenchymal cells and non-parachemyal cells (hepatocytes, hepatic stellate cells, and endothelial cells) derived from donated human liver. Thus, rather than letting the sometimes-random activities of cultured cells dictate which cells interact with each other, 3D printing allows one to specifically orchestrate a multicellular system that places different cell types in the appropriate proximity with one another.

Why is it important to construct a 3D bioprinted liver? Well, human studies show that many drugs can cause liver fibrosis. This is a complicated process that involves a series of inflammatory mediators. These pathways cannot be studied in the absence of immune cells. Co-cultures with undefined orientations may not be able to recapitulate the relationships among the cellular constituents and soluble factors. By systematically printing out the layers of cells, it is possible to place the hepatocytes in the appropriate proximity to the surrounding endothelial and immune cells. While Kupffer cells (liver macrophages) have been thought to play a role in the response to the inflammatory processes involved in fibrogenesis, they were not included in the current study; however, this is an underlying strength of the approach. Systematically adding in other cell types involved in a particular pathogenic process can be readily achieved under this paradigm.

The authors go on to use this model system to study the effects of methotrexate and thioacetamide. Methotrexate is a chemo-therapeutic and immune-suppressing agent. In addition to its use in cancer treatment, it is used in a wide variety of autoim-mune-related conditions. Thioacetamide is an organosulfur compound used in a variety of chemical applications. It is a well-known liver toxicant. Exposure to low doses of these compounds allowed for detection of hepatic cell damage, deposition of collagen seen in progressive fibrogenesis, and upregulation of cytokines and genes associated with fibrosis. The responses in

Toxicological Sciences

Toxicological Sciences is the official journal of SOT�

Editor-in-Chief Gary W� Miller and Managing Editor Virginia Hawkins are available to discuss the journal, your manuscripts, and other questions Monday to Wednesday

at the SOT Pavilion in the ToxExpo Exhibit Hall�

https://doi.org/10.1093/toxsci/kfw169

52

Mobile Event A

ppAW

ARD

S

these precisely bioprinted livers can inform the development of adverse outcome pathways, which are becoming more impor-tant in regulatory circles. This study provides proof-of-concept that bioprinted livers can be used to recapitulate many aspects of chemically-induced fibrogenic liver damage typically only seen in in vivo models. As toxicologists continue to search for models and systems that more faithfully recapitulate what is seen in humans, this study suggests that 3D printing of human cells to build complex systems may be a major driver of the future of toxicology.

Translational Impact Award

Jia-Sheng Wang

Jia-Sheng Wang, PhD University of Georgia, Athens, GA

Dr. Wang received his PhD from Boston University School of Medicine. Currently, Dr. Wang serves as the University of Georgia (UGA) Athletic Association professor in public health and department head of the Department of Environmental Health Science in the College of Public Health and is a full faculty member for the Interdisciplinary Toxicology Program at UGA.

Dr. Wang is regarded by many as a foremost expert in the world on the measurement of human exposure to mycotoxin, the public health impact from this exposure, and the translation of field-practical technologies for the mitigation of these toxins in humans. Over the past 10 years, Dr. Wang’s translational research has focused on green tea polyphenols and smectite clays. After years of collaboration with Timothy Phillips, PhD, Texas A&M University, testing the effectiveness of smectite clays as an enterosorbent to specifically bind to aflatoxins in many in vitro models and in many species of animals, Dr. Wang suggested moving to translational studies in high-risk areas. Together, they began the first human study to examine tolerance for a dosing protocol and short-term safety of smectite clay. Based on the results, four human intervention studies using smectite clay were conducted to examine efficacies for mitigation of exposure to aflatoxins and fumonisins in adults and children.

Further, Dr. Wang’s work helping to delineate the molecular epidemiology of hepatocellular carcinoma has provided major insight into human and animal exposures from aflatoxins, fumonisins, and other hazardous foodborne chemicals. Dr. Wang’s work has facilitated the development, application, and translation of critical molecular biomarkers of toxin exposure and effect. His groundbreaking, high-impact, and internationally-renowned research on aflatoxin ranks with the very best scientific discoveries for its importance to food safety, food quality, food security, and public health, especially in vulnerable communities. His studies are strategically relevant to 4.5 billion people (and their animals), who live in hot and humid climates and are frequently exposed to aflatoxins from contaminated diets.

Dr. Wang’s leadership, support, and unique insight have helped to achieve a significant translational impact to public health. The technology derived from Dr. Wang’s early work is now being translated to developing countries for sentinel detection of mycotoxins, and he has gained notable recognition internationally among scientists and administrators.

Translational Impact Award Lecture: Modulation of Toxic Effects and Human Disease Risks: From Synthetic Drugs to Natural Products, Tuesday, March 13, 11:00 am to 12:00 noon, CC Room 302�

Undergraduate Educator Award

Joshua P. Gray

Joshua P. Gray, PhD US Coast Guard Academy, New London, CT

Dr. Gray received his PhD in pathobiology from Penn State University in 2003. He joined the US Coast Guard Academy faculty in 2008 and has spent the past decade teaching undergraduate courses in toxicology, chemistry, biochemistry, microbiology, and the science of terrorism to cadets who become officers in the US Coast Guard.

As a postdoctoral fellow of the Joint Graduate Program in Toxicology at Rutgers, the State University of New Jersey, Dr. Gray designed the “Chemical and Biological Weapons” Bryne Seminar course, which introduces college freshman to the special interests of faculty members. He also mentored undergraduate students in research projects and taught several guest lectures to students at the Ernest Mario School of Pharmacy. Dr. Gray continues to serve as an adjunct graduate faculty member for the University of Maryland University College Biosecurity and Biodefense Master’s Program and the Lehigh University Chemistry Master’s Program.

Dr. Gray was named a fellow of the Partnership for Undergraduate Life Science Education (PULSE) in 2015, an organization supported by the National Science Foundation (NSF) and the Howard Hughes Medical Institute, which works to transform undergraduate life science education at the departmental level, and he also serves as a PULSE ambassador. Most recently, he co-moderated a conference of 21 institutions to facilitate their departmental transformation to incorporate evidence-based teaching practices, such as those spearheaded by the NSF’s Vision and Change in Undergraduate Biology Education initiative.

His two research programs are investigating mechanisms of toxicity of pancreatic beta cells and utilizing biocides to inhibit microbial-influenced corrosion and materials degradation. Cadets are active researchers in his laboratory, and many are coauthors on manuscripts from his laboratory.

An SOT member since 2001, Dr. Gray has been very active in SOT educational efforts. In 2013, he was appointed to the Undergraduate Education Subcommittee, and he served as co-chair and chair. He led the production of the Eminent Toxicologist Lecture Series, resulting in recordings of 14 expert toxicologists discussing their areas of expertise at a level appropriate for undergraduate students and a global audience. He and the committee also produced a recorded webinar series for undergraduate educators on topics from career development to laboratory exercises.


53

#20

18SO

T

#to

xexp

oAW

ARD

S

Colgate-Palmolive Postdoctoral Fellowship Award in In Vitro Toxicology

Zhengxi Wei

Zhengxi Wei, PhD, NIH, Rockville, MD

Project Title: Assessing Chemical Compounds that are Potential Skin Sensitization Hazards Using In Vitro Assays and Bio-Printed Human Skin Tissue

Syngenta Fellowship Award in Human Health Applications of New Technologies

Sharavan Ramachandran

Sharavan Ramachandran, PhD, Texas Tech University Health Science Center, Amarillo, TX

Project Title: Discovery of Anti-Cancer Effects of Pimavanserin Tartrate in Pancreatic Cancer

Colgate-Palmolive Grants for Alternative Research

Kristen Comfort

Kristen Comfort, PhD, University of Dayton, Dayton, OH

Project Title: Development of an Enhanced In Vitro Detoxification Model for Nanotoxicology

Valentina Galbiati

Valentina Galbiati, PhD, University of Milan, Milan, Italy

Project Title: Understanding the Role of MicroRNAs in the Regulation of Chemical Allergen Potency

Colgate-Palmolive Awards for Student Research Training in Alternative Methods

Ian Huck

Ian Huck, BS, University of Kansas Medical Center, Kansas City, KS

Project Title: Modeling of PFOA and PFOS Developmental Hepatotoxicity Using iPS Cell Derived Human Hepatocytes

Host Institution: Medical University of South Carolina

Lauren Lewis

Lauren Lewis, BS, Texas A&M University, College Station, TX

Project Title: Epigenetic and Genotoxic Effects of 1,3-butadiene in a Human iPSC Population Model

Host Institution: Cellular Dynamics International

Supported Award Recipients

Call for 2019 Nominations

www.toxicology.org/awards

Submit your nominations by October 9, 2018.

&Awards

Fellowships

http://www.toxicology.org/awards

54

Mobile Event A

pp

Building the Future of Toxicology

The SOT Endowment Fund supports programs, individuals, and research

that are advancing toxicology.

Become a contributor today!

Visit www.toxicology.org/endowment


http://www.toxicology.org/endowment

#20

18SO

T

#to

xexp

o

55

AWA

RDS

SOT Endowment Fund 2017 Award RecipientsMary Amdur Student Award Fund

Katherine Duke, BS, MS, North Carolina State University, Raleigh, NC

Sheryse Taylor, BSc, Rutgers, The State University of New Jersey, Piscataway, NJ

Edward W. Carney Trainee Award Fund Edith Marie McKenzie, BS, MS, University of Georgia, Athens, GA

Karilyn Sant, PhD, MPH, University of Massachusetts, Amherst, MA

Young Soo Choi Student Scholarship Award Fund

Juyoung Shim, PhD candidate, University of Maine, Orono, ME

Laxman S. Desai Association of Scientists of Indian Origin Student Award Fund

Adhithiya Charli Manohar Charle, BS, Iowa State University, Ames, IA

John Doull Student Award Fund Tanzir Mortuza, BS, University of Georgia, Brookhaven, GA

Education Fund: Undergraduate Educator Award

Karen E. Stine, PhD, Auburn University at Montgomery, Montgomery, AL

Founders Award Meryl H. Karol, PhD, ATS, University of Pittsburgh, Pittsburgh, PA

Angelo Furgiuele Young Investigator Technology Award

Katherine (Katie) O’Shaughnessy, BA, PhD, ORISE Postdoctoral Fellow, US Environmental Protection Agency, Research Triangle Park, NC

Donald E. Gardner Inhalation Toxicology Education Award Fund

Matthew McGraw, MD, University of Colorado School of Medicine, Aurora, CO

Perry J. Gehring Biological Modeling Student Award Fund

Marie-Emilie Willemin, PhD, PharmD, US FDA NCTR, Beerse, Belgium

Perry J. Gehring Diversity Student Travel Award Fund

Kaylin Marie White, Spelman College, Atlanta, GA

Perry J. Gehring Risk Assessment Best Postdoctoral Fellow Abstract Award Fund

Fabian Grimm, PhD, Texas A&M University, College Station, TX

Perry J. Gehring Risk Assessment Student Award Fund

Abhishek Venkatratnam, BTech, MS, University of North Carolina at Chapel Hill, NC

HESI Young Investigator Endowment Award

Anthony Franchini, PhD, University of Rochester, Rochester, NY

56

Mobile Event A

ppAW

ARD

S

Vera W. Hudson and Elizabeth K. Weisburger Scholarship Fund

Katelyn Lavrich, BS, University of North Carolina at Chapel Hill, Chapel Hill, NC

Kristal Rychlik, BS, Texas A&M University, College Station, TX

Lisa Weatherly, BA, University of Maine, Orono, ME

Frank C. Lu Food Safety Student Award Fund

Blake Rushing, BS, East Carolina University, Greenville, NC

Jean Lu Student Scholarship Award Fund Kathy Xue, BS, University of Georgia, Athens, GA

Roger O. McCellan Student Award Fund Katharine Horzmann, DVM, MS, MPH, DACVP, Purdue University, West Lafayette, IN

Harihara Mehendale Association of Scientists of Indian Origin Student Award Fund

Diptadip Dattaroy, MS, University of South Carolina, Columbia, SC

Hanumantha Rao Madala, MS, Texas Tech University Health Sciences Center, Amarillo, TX

Molecular Biology Specialty Section Postdoctoral Fellow Research Award

Sarah Lacher, BS, PhD, University of Minnesota, Duluth, MN

Molecular Biology Student Award Fund Gloria Garcia, BS, Oregon State University, Corvallis, OR

Elizabeth Mutter-Rottmayer, BS, University of North Carolina at Chapel Hill, Chapel Hill, NC

Amin Sobh, BSc, MSc, University of California, Berkeley, Berkeley, CA

Sheldon D. Murphy Award Fund Kelly Fader, BSc, Michigan State University, East Lansing, MI

Gopi Gadupudi, PhD, University of Iowa, Iowa City, IA

Cory Gerlach, BS, Harvard Medical School, Boston, MA

Nehal Gupta, MPharm, BPharm, Texas Tech University Health Sciences Center, Amarillo, TX

Madelyn Huang, BS, University of North Carolina at Chapel Hill, Chapel Hill, NC


57

#20

18SO

T

#to

xexp

oAW

ARD

S

Toshio Narahashi Neurotoxicology Fellowship Award Fund

Gelareh Alam, PharmD, PhD, Northeast Ohio Medical University, Rootstown, OH

Shelbie Burchfield, BS, Northeast Ohio Medical University, Rootstown, OH

Pallavi Pilaka, Virginia Commonwealth University, Glen Allen, VA

Emil A. Pfitzer Drug Discovery Postdoc Award Fund

Xi Li, PhD, Texas A&M University, College Station, TX

Sarah Thacker, BS, PhD, University of North Carolina at Chapel Hill, Research Triangle Park, NC


Emil A. Pfitzer Drug Discovery Student Award Fund

Wenyi Wang, PhD, Rutgers, The State University of New Jersey, Camden, NJ

Elijah Weber, BS, University of Washington, Seattle, WA

Gabriel L. Plaa Education Award Fund Joseph Cichocki, PhD, Texas A&M University, College Station, TX

Matthew Dodson, MS, PhD, University of Arizona College of Pharmacy, Tucson, AZ

Gregory Smith, PhD, University of North Carolina, Carrboro, NC

Regulatory and Safety Evaluation Specialty Section Student Research Endowment Award(not pictured) Rosa Chan, BS, University of California San Francisco, San Francisco, CA

Esther E. Omaiye, BS, MS, University of California Riverside, Riverside, CA

Nikaeta Sadekar, MS, St. John’s University, New York, NY

Brett Winters, BS, University of North Carolina at Chapel Hill, Chapel Hill, NC

Renal Toxicology Fellowship Award Fund Qian Lin, PhD, University of Louisville, Louisville, KY


Robert J. Rubin Student Travel Award Fund

Yvonne Chang, BS, Oregon State University, Corvallis, OR

Gopi Gadupudi, PhD, University of Iowa, Iowa City, IA

Dharm V. Singh Association of Scientists of Indian Origin Student Award Fund

Satya Achanta, DVM, PhD, Duke University School of Medicine, Durham, NC


58

Mobile Event A

ppAW

ARD

S

Dharm V. Singh Carcinogenesis Award Fund

Nehal Gupta, MPharm, BPharm, Texas Tech University Health Sciences Center, Amarillo, TX

Carl C. Smith Student Mechanisms Award Fund

Emma Bowers, MS, University of North Carolina at Chapel Hill, Chapel Hill, NC

Kelly Fader, BSc, Michigan State University, East Lansing, MI

Bryan Harder, BS, University of Arizona, Tucson, AZ

Dahea You, PharmD, PhD Candidate, Rutgers, The State University of New Jersey, Piscataway, NJ

Ronald G. Thurman Student Travel Award Fund

Diptadip Dattaroy, MS, University of South Carolina, Columbia, SC

Ramiya Kumar, PhD, Clemson University, Clemson, SC

Yu Syuan Luo, PhD, Texas A&M University, College Station, TX

Toxicologists of African Origin Endowment Fund

Sheryse Taylor, BSc, Rutgers, The State University of New Jersey, Piscataway, NJ

Toxikon, a Preclinical Tox Organization, and Dr. Dharm Singh ASIO Award Fund

Krishnaprahlad Maremanda, MS Pharm, Niper, Sas Nagar, Punjab, India

Women in Toxicology SIG Celebrating Women in Toxicology Award

Alison Sanders, PhD, MS, Icahn School of Medicine at Mount Sinai, New York, NY

Jessica Sapiro, MS, University of Arizona/Wayne State University, Detroit, MI


Call for 2019 Nominations

www.toxicology.org/awards

Submit your nominations by October 9, 2018.

&Awards Fellowships

More than 200 distinguished toxicologists, postdoctoral researchers, and students are honored each year.

Award deadlines vary for SOT Endowment Fund- and SOT Component Group-supported awards. Visit the SOT website for up-to-date awards deadlines.


SOT Award Recipients · Garrobo,” is a flamenco guitarist based in San Antonio. He studied the...

Documents

Transcript of SOT Award Recipients · Garrobo,” is a flamenco guitarist based in San Antonio. He studied the...